A new device for detecting illicit plutonium

September 01, 1999

WOULD-BE plutonium smugglers could find life tougher thanks to a radiation detector based on optical fibres. The glass fibres emit light when bombarded with the neutrons that plutonium emits. The detector, which was developed at the Pacific Northwest National Laboratory in Richland, Washington, may also enable doctors to monitor the precise dose of radiation they are giving to patients.

"Knowing that neutrons are around is a big deal if you're looking for plutonium," says Mary Bliss, principal investigator on the project. "Other than a few applications in geology, there's no reason why someone would walk through an airport with a neutron source." However, traditional detectors-which consist of a metal tube filled with pressurised gas-are bulky, cannot safely be shipped by air, and can be damaged by vibrations.

The new fibre-optic detector is light and flexible. It is made from layers of plastic sandwiched between layers of the special fibres, which are impregnated with cerium (III) ions and the isotope lithium-6. When a neutron hits the sandwich, the plastic slows it down. It then collides with a lithium-6 atom, smashing it apart and releasing a shower of electrons.

The electrons excite nearby cerium(III) ions, which emit photons of visible light that travel to the ends of the fibres, where they can be detected. If four or more photons are detected within 200 nanoseconds, a neutron is almost certainly responsible.

"People have been trying since the early 1960s to use this stuff as radiation detectors," says Bliss. But making the necessary glass has proved to be the stumbling block.

The trouble is that cerium(III) is easily oxidised to cerium(IV). And if the fibres contain any cerium(IV) the detector won't work, because cerium(IV) will absorb any photons that are produced. To avoid contamination, the fibre must be made in a low-oxygen atmosphere, which requires precise control of the manufacturing process.

The laboratory has licensed the technology to Canberra Industries of Meriden, Connecticut. The company has produced a prototype plutonium detector, and the International Atomic Energy Agency has installed a unit at the border between Austria and Hungary.

So far, it has not uncovered any plutonium. It was, however, triggered by a woman on a bus who had recently received radiation therapy and was emitting gamma rays, to which the detector is also sensitive.

Glenn Knoll, a nuclear engineer at the University of Michigan is impressed by Bliss's technical accomplishment, but is less convinced of the practical value of the detector. "Although I can certainly recognise the novelty of what has been done," says Knoll, "I cannot, in all honesty, point to an important application where I think it has made a big difference."

But plutonium detection is not the only use for these fibres. They are also being tested at the University of Washington's Nuclear Radiation Center in Pullman as a way of monitoring the dose delivered to a brain tumour during radiation therapy. Bundles of the fibre are taped to the patient's skull and placed in the mouth and sinuses, allowing medical staff to deliver a precise dose of radiation.
-end-
Author: Henry Bortman
New Scientist issue 4 September 99

PLEASE MENTION NEW SCIENTIST AS THE SOURCE OF THIS STORY AND, IF PUBLISHING ONLINE, PLEASE CARRY A HYPERLINK TO : http://www.newscientist.com

New Scientist

Related Radiation Therapy Articles from Brightsurf:

Pulmonary artery thrombosis a complication of radiation therapy
According to ARRS' American Journal of Roentgenology, the imaging findings of in situ pulmonary artery thrombosis (PAT) associated with radiation therapy (RT) are different from those of acute pulmonary emboli and do not appear to embolize.

New approach for calculating radiation dosimetry allows for individualized therapy
Researchers have developed a simplified process that could enhance personalization of cancer therapy based on a single nuclear medicine scan.

Developing microbeam radiation therapy (MRT) for inoperable cancer
An innovative radiation treatment that could one day be a valuable addition to conventional radiation therapy for inoperable brain and spinal tumors is a step closer, thanks to new research led by University of Saskatchewan (USask) researchers at the Canadian Light Source (CLS).

Travel considerations specified for 177Lu-DOTATATE radiation therapy patients
Researchers and patient advocates have addressed the challenges related to traveling after receiving 177Lu-DOTATATE radiation therapy in a study published in the April issue of The Journal of Nuclear Medicine.

A new way to monitor cancer radiation therapy doses
More than half of all cancer patients undergo radiation therapy and the dose is critical.

AI can jump-start radiation therapy for cancer patients
Artificial intelligence can help cancer patients start their radiation therapy sooner -- and thereby decrease the odds of the cancer spreading -- by instantly translating complex clinical data into an optimal plan of attack.

Towards safer, more effective cancer radiation therapy using X-rays and nanoparticles
X-rays could be tuned to deliver a more effective punch that destroys cancer cells and not harm the body.

Radiation therapy effective against deadly heart rhythm
A single high dose of radiation aimed at the heart significantly reduces episodes of a potentially deadly rapid heart rhythm, according to results of a phase one/two study at Washington University School of Medicine in St.

New mathematical model can improve radiation therapy of brain tumours
Researchers have developed a new model to optimize radiation therapy and significantly increase the number of tumor cells killed during treatment.

Using artificial intelligence to deliver personalized radiation therapy
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to personalize the dose of radiation therapy used to treat cancer patients.

Read More: Radiation Therapy News and Radiation Therapy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.